Table 1.

Predicted prevalence of esophageal cancer and the number of people diagnosed with esophageal cancer from 2013 to 2030 in China, by sex.

Year	Males			Females			Total
	Prevalence (per 100,000)	Cases, n	Prevalence (per 100,000)		Cases, n	Prevalence (per 100,000)		Cases, n
2013	82.0	575,500	38.9		260,100	61.0		835,600
2014	86.1	607,600	40.4		270,900	63.8		878,500
2015	89.0	631,100	41.1		277,000	65.6		908,100
2016	91.1	648,600	41.3		279,900	66.8		928,500
2017	92.4	661,900	41.1		280,500	67.4		942,300
2018	93.4	672,300	40.7		279,400	67.7		951,600
2019	94.3	680,600	40.2		277,100	67.9		957,700
2020	94.9	687,100	39.6		273,800	67.9		961,000
2021	95.3	691,800	38.9		269,800	67.7		961,500
2022	95.6	695,500	38.1		265,300	67.5		960,700
2023	95.8	698,500	37.3		260,500	67.2		959,000
2024	95.9	701,100	36.5		255,600	66.8		956,600
2025	96.0	703,400	35.6		250,500	66.4		953,900
2026	96.1	704,700	34.8		245,300	66.0		950,000
2027	96.2	705,700	34.0		240,000	65.7		945,700
2028	96.3	706,500	33.2		234,700	65.3		941,200
2029	96.4	707,100	32.4		229,500	64.9		936,500
2030	96.4	707,500	31.6		224,300	64.5		931,800